Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors

/in
Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors [PDF] [DOI] [PubMed]
You might also like
Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation
IRGM1 links mitochondrial quality control to autoimmunity
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity
IL10 restrains autoreactive B cells in transgenic mice expressing inactive RAG1
Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia
Regulatory T Cell-Derived TGF-β1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development